GlassScriptPhysician profile
Nadya M Modlin
NPI 1063721264
$1,459.62
in general payments reported to CMS, 2019-2025
16 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $912 · 2022: $209 · 2023: $101 · 2024: $135 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $819.95 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $149.25 | 2022 | |
| Bausch Health US, LLC | $82.21 | 2022-2025 | Aplenzin, Wellbutrin |
| Abbvie INC. | $71.57 | 2023-2025 | |
| Pfizer INC. | $56.21 | 2023-2024 | |
| Novo Nordisk INC | $42.64 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.19 | 2021-2022 | |
| Lilly USA, LLC | $35.38 | 2021-2024 | Zepbound, Mounjaro |
| Corium, LLC | $31.97 | 2025 | Azstarys |
| Viiv Healthcare Company | $28.68 | 2024 | Apretude |
| Exact Sciences Corporation | $23.69 | 2024 | Cologuard Collection Kit |
| Phadia US INC. | $18.82 | 2021 | |
| Gilead Sciences, INC. | $16.20 | 2023 | |
| Genentech USA, INC. | $15.45 | 2021 | |
| Axsome Therapeutics, INC. | $14.15 | 2024 | Auvelity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $13.26 | 2023 | Xelstrym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadya Modlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.